In a significant development for the medical device industry, CoorsTek Bioceramics has emerged victorious in a trademark dispute at the U.S. Court of Appeals for the Federal Circuit. The court’s decision affirms CoorsTek’s right to market and sell its Permallon® Tru ceramic hip components in the United States, marking a crucial win in the company’s ongoing legal battle with Ceramtec GmbH.
The recent ruling upholds the 2022 decision by the U.S. Patent and Trademark Office’s Trademark Trial and Appeal Board (TTAB) to cancel Ceramtec’s trademark registrations related to the pink color of ceramic hip components. This legal victory is seen as a pivotal moment in ensuring diverse supply options for critical medical devices.
Jonathan Coors, CEO of CoorsTek, emphasized the broader implications of this decision, stating, ‘Alternative sourcing of these components is necessary to prevent supply shortages for this critical care market. The U.S. Court of Appeals decision marks another victory for CoorsTek in this case, but it is ultimately patients across the globe who will benefit.’
The dispute dates back to 2014 when CoorsTek initiated legal proceedings following Ceramtec’s attempts to enforce trademark and trade dress claims on the pink color of its ceramic hip components. CoorsTek, which entered the hip arthroplasty industry in 2013 with its Permallon® Tru technical ceramic material, argued that the pink coloration was a natural byproduct of the chromium oxide additive used to enhance the material’s performance.
The TTAB’s 2022 ruling, now affirmed by the Court of Appeals, found that the pink color is functional and results naturally from following the teachings in Ceramtec’s expired patent on the material. This decision effectively nullifies Ceramtec’s claim to exclusive rights over the pink color in ceramic hip components.
Lucian Strong, President of CoorsTek Bioceramics, highlighted the company’s commitment to innovation and quality, stating, ‘Products manufactured from Permallon® Tru ceramic material demonstrate exceptional mechanical performance and durability. We are pleased to continue offering these products to leading medical device OEMs who have come to rely upon high-performance, high-quality components provided by CoorsTek.’
The implications of this legal victory extend beyond CoorsTek and the immediate dispute. It opens the door for increased competition and innovation in the medical device industry, particularly in the field of hip arthroplasty. By allowing multiple manufacturers to produce and market pink ceramic hip components, the decision could lead to improved availability, potentially lower costs, and greater choice for healthcare providers and patients.
CoorsTek’s Permallon® Tru hip components have already gained traction in the global market, with registrations for use by CoorsTek Bioceramics customers in multiple locations including the United States, Korea, China, and the European Union. This widespread adoption underscores the importance of the Court of Appeals decision in maintaining and potentially expanding access to these critical medical devices.
The legal battle’s resolution also highlights the complex interplay between intellectual property rights and public health concerns in the medical device industry. By ruling in favor of CoorsTek, the court has effectively prioritized the functional aspects of the product over aesthetic trademark claims, potentially setting a precedent for similar cases in the future.
As the medical device industry continues to evolve, this decision may encourage further innovation and competition in the development of high-performance materials for orthopaedic and other medical applications. It also serves as a reminder of the critical role that legal frameworks play in shaping the landscape of healthcare technology and patient care.
With this legal hurdle cleared, CoorsTek Bioceramics is poised to strengthen its position in the bioceramics market, leveraging its century-long expertise in technical ceramics to advance the field of medical implants. The company’s continued focus on research and development, coupled with its proven track record in manufacturing high-quality components,
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is CoorsTek Wins Appeal in Trademark Dispute Over Pink Ceramic Hip Components.